Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases.
Gottschalk, Carl Gunnar, Peterson, Daniel, Armstrong, Jan et al. · Infectious agents and cancer · 2023 · DOI
Quick Summary
This review article examines how viral infections—including long COVID, EBV, and others—can trigger severe, lasting fatigue and related symptoms. The authors explore the biological mechanisms that might explain why some patients develop chronic muscle fatigue and brain fog after viral illness, and compare these processes to ME/CFS. This research suggests that multiple different viruses may cause fatigue through similar pathways in the body.
Why It Matters
This work is important because it identifies potential shared molecular mechanisms across ME/CFS and post-viral fatigue syndromes, which could guide future research into treatments applicable to multiple conditions. Understanding these commonalities may help researchers and clinicians recognize ME/CFS as a post-viral phenomenon with clear biological underpinnings rather than a psychiatric disorder. The review provides a framework for investigating why some patients progress from acute infection to chronic debilitating fatigue.
Observed Findings
Long-haul COVID affects at least 10% of COVID-19 infected individuals with persistent symptoms lasting months
Long-haul COVID and other viral diseases (HHV-6, EBV, Powassan, HIV) share overlapping symptom profiles including muscle fatigue, dizziness, depression, and chronic inflammation
ME/CFS displays pathological similarities to virus-triggered muscle fatigue syndromes
Multiple viral infections can trigger prolonged fatigue and neuropsychiatric complications beyond the acute infection period
Inferred Conclusions
Similar molecular mechanisms may underlie fatigue across different post-viral conditions, suggesting a convergent pathological pathway
Viral-triggered chronic fatigue syndromes share enough clinical and biological features with ME/CFS to warrant investigating common disease mechanisms
Understanding these shared mechanisms could lead to unified treatment approaches for post-viral fatigue
Remaining Questions
Which specific molecular pathways (mitochondrial dysfunction, immune dysregulation, microbiome changes, etc.) are most critical in driving persistent fatigue across different viral infections?
Why do some infected individuals progress to chronic fatigue while others recover fully, and what genetic or immunological factors predict this risk?
What This Study Does Not Prove
This review article does not prove causation or present new experimental evidence—it synthesizes existing literature and proposes hypothetical mechanisms. It does not establish which molecular pathways are primary drivers versus secondary consequences of fatigue, nor does it validate proposed mechanisms in ME/CFS or long COVID patients. The overlap in clinical symptoms between conditions does not prove they share identical biological origins.